Soluble Epoxide Hydrolase and Diabetes Complications

Area of Science:

• Endocrinology and Metabolism
• Molecular Biology
• Neuroscience

Background:

• Type 2 diabetes mellitus (T2DM) is associated with significant microvascular (neuropathy, retinopathy, nephropathy, cerebral small vessel disease) and macrovascular complications (heart failure, peripheral arterial disease, stroke).
• T2DM also elevates risks for depression and dementia, with underlying mechanisms largely unknown.
• The cytochrome P450-soluble epoxide hydrolase (CYP-sEH) pathway has been suggested to play a role in various diabetes-related complications.

Purpose of the Study:

• To review existing clinical and animal literature on the involvement of the CYP-sEH pathway in T2DM complications across different organ systems.
• To explore potential mechanisms linking the CYP-sEH pathway to T2DM complications.
• To highlight the therapeutic potential of targeting the CYP-sEH pathway for T2DM management.

Main Methods:

• Comprehensive review of clinical and animal studies.
• Analysis of evidence implicating the CYP-sEH pathway in T2DM pathogenesis.
• Identification and discussion of molecular and cellular mechanisms.

Main Results:

• Evidence suggests the CYP-sEH pathway is involved in multiple T2DM complications, affecting various organ systems.
• Key mechanisms potentially linking CYP-sEH to complications include inflammation, fibrosis, mitochondrial dysfunction, endoplasmic reticulum stress, unfolded protein response, and autophagy.
• These findings underscore the pathway's relevance to diabetes-related pathologies.

Conclusions:

• The CYP-sEH pathway represents a promising target for therapeutic intervention in T2DM complications.
• Understanding the role of CYP-sEH in mechanisms like inflammation and ER stress could lead to novel treatment strategies.
• Targeting the CYP-sEH pathway may offer a unified approach to preventing and treating microvascular complications in T2DM affecting the brain and other organs.